This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages without signing in

Epidemiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

epidemiology

Globally, 5% of TB cases were estimated to have had MDR-TB in 2013 (3.5% of new and 20.5% of previously treated TB cases).

Drug resistance surveillance data show that an estimated 480 000 people developed MDR-TB in 2013 and 210 000 people died.

Extensively drug-resistant TB (XDR-TB) has been reported by 100 countries in 2013.

  • on average, an estimated 9% of people with MDR-TB have XDR-TB.

If all notified TB patients (6.1 million, new and previously treated) had been tested for drug resistance in 2013, an estimated 300 000 cases of MDR-TB would have been detected.

  • 136 000 of the estimated 300 000 MDR-TB patients who could have been detected were diagnosed and notified
  • this represents a tripling in MDR-TB detection compared with 2009.

27 high burden countries for MDR-TB have been recognised which accounts for more than 85% of cases

  • highest number of cases were reported from China, India, and the Russian Federation
  • the highest proportions are found in eastern Europe and Central Asia, with around 20% of new cases and 50% of previously treated cases having MDR-TB

In the UK

  • 1.4% of new and 5.7% of previously treated patients have MDR-TB
    • 89% of these patients are born outside the United Kingdom

Reference:

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.